Oscar C. Reina-Bedoya

Crewe Road
Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma.

HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 21, 2025

Combined targeting of PRDX6 and GSTP1 as a potential differentiation strategy for neuroblastoma treatment.

Combined targeting of PRDX6 and GSTP1 as a potential differentiation strategy for neuroblastoma treatment.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 18, 2025

EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity.

EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity.

Journal: Oncoimmunology

Published: April 07, 2025

Correction: The long non-coding RNA Cerox1 is a post transcriptional regulator of mitochondrial complex I catalytic activity.

Correction: The long non-coding RNA Cerox1 is a post transcriptional regulator of mitochondrial complex I catalytic activity.

Journal: eLife

Published: February 03, 2025

Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma.

Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma.

Journal: NPJ precision oncology

Published: December 30, 2024

Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.

Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.

Journal: EMBO molecular medicine

Published: December 04, 2024

The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic Approaches.

The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic Approaches.

Journal: Cancers

Published: April 08, 2024

Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development.

Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development.

Journal: Cancers

Published: June 22, 2023

Publisher Correction: Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome.

Publisher Correction: Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome.

Journal: Nature metabolism

Published: September 08, 2022

Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma.

Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 22, 2021

Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome.

Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome.

Journal: Nature metabolism

Published: January 25, 2021

Chromaffin Cells with Sympathoblast Signature: Too Similar to Keep Apart?

Chromaffin Cells with Sympathoblast Signature: Too Similar to Keep Apart?

Journal: Cancer cell

Published: January 01, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026